Pulmatrix - Stock Price History | PULM

Historical daily share price chart and data for Pulmatrix since 2023 adjusted for splits. The latest closing stock price for Pulmatrix as of January 27, 2023 is 4.07.
  • The all-time high Pulmatrix stock closing price was 3625.00 on March 21, 2014.
  • The Pulmatrix 52-week high stock price is 8.60, which is 111.3% above the current share price.
  • The Pulmatrix 52-week low stock price is 3.17, which is 22.1% below the current share price.
  • The average Pulmatrix stock price for the last 52 weeks is 4.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pulmatrix Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 5.1398 9.1000 9.1000 3.2000 3.8800 -55.67%
2021 20.1875 25.2000 53.0000 8.1680 8.7520 -63.23%
2020 27.5072 32.4000 39.4000 18.3520 23.8000 38.37%
2019 22.0118 54.0000 65.6600 13.6000 17.2000 -64.18%
2018 134.3043 284.0000 398.0000 48.0200 48.0200 -82.97%
2017 470.0300 119.9800 1020.0000 110.2000 282.0000 138.98%
2016 419.7376 766.0000 850.0000 112.0000 118.0000 -85.95%
2015 1508.5311 1760.0000 2530.0000 682.0000 840.0000 -52.00%
2014 2732.5353 3625.0000 3625.0000 1680.0000 1750.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.005B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $155.188B 9.47
GSK (GSK) United Kingdom $72.345B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.333B 19.34
Ginkgo Bioworks Holdings (DNA) United States $3.395B 0.00
Myovant Sciences (MYOV) United Kingdom $2.604B 0.00
Arcus Biosciences (RCUS) United States $1.672B 25.10
Biohaven (BHVN) United States $1.264B 0.00
Emergent Biosolutions (EBS) United States $0.655B 5.15
ADC Therapeutics SA (ADCT) Switzerland $0.363B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.073B 0.00
Gelesis Holdings (GLS) United States $0.027B 0.00
SQZ Biotechnologies (SQZ) United States $0.025B 0.00